Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 10:15:7241-7248.
doi: 10.2147/IDR.S386497. eCollection 2022.

Prevalence of Multidrug-Resistant TB Among Smear-Positive Pulmonary TB Patients in Banadir, Somalia: A Multicenter Study

Affiliations

Prevalence of Multidrug-Resistant TB Among Smear-Positive Pulmonary TB Patients in Banadir, Somalia: A Multicenter Study

Abdirahman Mohamed Hassan Dirie et al. Infect Drug Resist. .

Abstract

Background: Tuberculosis (TB) is an infectious disease that is the second most common cause of death from a single infectious agent. TB infection affects anyone, regardless of age, gender, and ethnicity. Drug-resistant TB is a serious public health problem, which needs treatment with a second-line anti-TB drug and it includes poly-drug resistance (PDR), multi-drug resistance (MDR), and extensive drug resistance (XDR). The goal of this research is to find out the prevalence of MDR TB among pulmonary TB patients in Banadir, Somalia.

Methods: This was a multicenter retrospective review of data involving 1732 smear-positive pulmonary TB patients visiting Banadir TB centers between July 1, 2019 and June 30, 2020. Demographic, clinical, and drug susceptibility data were retrieved from TB treatment cards. The data were analyzed using Statistical Package for Social Sciences (SPSS) software (IBM SPSS Statistics version 26).

Results: All 1732 pulmonary TB cases were previously diagnosed by the Gene Xpert MTB/RIF test. Among them, 70.4% (1219/1732) were males. The mean age was 31.77 years. Overall, the prevalence of drug resistance TB was 10.56% (183/1732). The MDR TB was 1.96%, poly-drug resistance (PDR) was 0.12%, and extensive drug resistance was 0.06%.

Conclusion: This study showed a prevalence of MDR-TB among pulmonary TB patients, which is similar to some of the eastern African countries.

Keywords: MDR; TB; XDR; drug-resistance; poly-drug resistance.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Number of patients with drug sensitive TB and those with DR TB.
Figure 2
Figure 2
Gender of all TB patients in the study.

References

    1. World Health Organization. Global Tuberculosis Report [Internet]; 2021. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globa.... Accessed December 5, 2022.
    1. World Health Organization (WHO). WHO Report on TB 2020 [Internet]. Vol. 1. World Health Organization; 2020.
    1. World Health Organization (WHO). Operational handbook on tuberculosis [Internet]. WHO operational handbook on tuberculosis Module 5; 2022. 45. Available from: https://apps.who.int/iris/bitstream/handle/10665/340256/9789240022614-en.... Accessed December 5, 2022.
    1. Tembo BP, Malangu NG. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana. BMC Infect Dis. 2019;19(1):1–8. doi:10.1186/s12879-019-4375-7 - DOI - PMC - PubMed
    1. Rudnicka E, Napiera P, Pod A, Smolarczyk R, Grymowicz M. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company’s public news and information; 2020.

LinkOut - more resources